| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6291223cb0754d524a5f6d760cd8ed76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d557b4a2eeaf8a005b3f89b6a46888a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05efe293037109ead58eb586b41d9bfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d58eb4c147f1820c93ecc7435b8729b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a76d52fa412e561281a89c27c2d8962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_722beddfab0fdaf557a6c4510ed1df75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5af571feac8553f689eaa4dcb37253e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8146 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
2003-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3787b1fb65ed3f2b6a7d3e53ff35bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40818692244a6079fd3f81b6de9a2dd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e36042fef3b0b076a2c5684703ebfedb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a43fa5367b7a321967a44d9f6b5824c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a2b6cd98450615ce7ca6d7f40071252 |
| publicationDate |
2003-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03057884-A1 |
| titleOfInvention |
Human serum albumin-timp2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-timp2 fusion protein |
| abstract |
The present invention provides a human serum albumin-TIMP2 fusion protein having the amino acid sequence set forth in SEQ ID NO. 10, a polynucleotide encoding the same and a vector comprising the polynucleotide, a host cell transformed with the vector, a method for producing the human serum albumin-TIMP2 fusion protein and a pharmaceutical composition comprising the human serum albumin-TIMP2 fusion protein. The human serum albumin-TIMP2 fusion protein is stable and retains the activity of TIMP2, thus it can be used as a pharmaceutical composition to treat diseases related to angiogenesis and/or metastasis of cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7262287-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007048100-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007048102-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007048100-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007048102-A2 |
| priorityDate |
2002-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |